1. Home
  2. ZTO vs CANF Comparison

ZTO vs CANF Comparison

Compare ZTO & CANF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ZTO

ZTO Express (Cayman) Inc. each representing one ordinary share.

N/A

Current Price

$19.39

Market Cap

16.3B

ML Signal

N/A

Logo Can-Fite Biopharma Ltd Sponsored ADR (Israel)

CANF

Can-Fite Biopharma Ltd Sponsored ADR (Israel)

N/A

Current Price

$2.22

Market Cap

6.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ZTO
CANF
Founded
2002
1994
Country
China
Israel
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.3B
6.7M
IPO Year
2016
2011

Fundamental Metrics

Financial Performance
Metric
ZTO
CANF
Price
$19.39
$2.22
Analyst Decision
Buy
Analyst Count
18
0
Target Price
★ $27.95
N/A
AVG Volume (30 Days)
★ 2.5M
212.7K
Earning Date
11-18-2026
09-08-2026
Dividend Yield
★ 3.45%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$17.33
N/A
Revenue Next Year
$8.10
N/A
P/E Ratio
$21.83
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$18.11
$0.17
52 Week High
$26.20
$10.40

Technical Indicators

Market Signals
Indicator
ZTO
CANF
Relative Strength Index (RSI) 34.26 38.34
Support Level $18.95 $2.16
Resistance Level $22.84 $2.39
Average True Range (ATR) 0.34 0.07
MACD 0.00 0.04
Stochastic Oscillator 24.77 44.00

Price Performance

Historical Comparison
ZTO
CANF

About ZTO ZTO Express (Cayman) Inc. each representing one ordinary share.

ZTO Express is China's largest express delivery company by parcel volume, with a volume share of 20.1% in 2026. It operates a network partner model where it provides line-haul transportation and sorting services, while its local network partners provide first-mile pickup and last-mile delivery services under the ZTO brand name. Headquartered in Shanghai, the company was founded in 2002 by Meisong Lai, who remains chair, CEO, and a major shareholder with 78.7% voting rights as of March 31, 2026. ZTO's strategic shareholder is leading China e-commerce company Alibaba Group with around a 9.3% interest.

About CANF Can-Fite Biopharma Ltd Sponsored ADR (Israel)

Can Fite Biopharma Ltd is a clinical-stage biopharmaceutical company. The company focuses on developing orally bioavailable small-molecule drugs targeting the A3 adenosine receptor for treating cancer, inflammatory diseases, liver disorders, and related conditions. It has a pipeline of proprietary drug candidates in Phase II and Phase III clinical development. The company's platform targets the A3 adenosine receptor (A3AR), which is more expressed in inflammatory and cancerous cells than in normal cells. Its pipeline drugs include Namodenoson, Piclidenoson, CF602, and Cannabinoids.

Share on Social Networks: